{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:23:54Z","timestamp":1787019834823,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,30]],"date-time":"2011-03-30T00:00:00Z","timestamp":1301443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1748-717x-6-28","type":"journal-article","created":{"date-parts":[[2011,4,6]],"date-time":"2011-04-06T02:13:51Z","timestamp":1302056031000},"source":"Crossref","is-referenced-by-count":32,"title":["Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: Is there a role for radiation therapy?"],"prefix":"10.1186","volume":"6","author":[{"given":"Rusen","family":"Cosar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Uzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusun","family":"Tokatli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bengu","family":"Denizli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mert","family":"Saynak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrin","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sernaz","family":"Uzunoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaattin","family":"Ozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atakan","family":"Sezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamuran","family":"Ibis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcu","family":"Uregen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuslat","family":"Yurut-Caloglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafer","family":"Kocak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,30]]},"reference":[{"issue":"9472","key":"355_CR1","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG)","year":"2005","unstructured":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005,365(9472):1687-717. 10.1016\/S0140-6736(05)66544-0","journal-title":"Lancet"},{"key":"355_CR2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.radonc.2007.05.011","volume":"84","author":"M Overgaard","year":"2007","unstructured":"Overgaard M, Nielsen HM, Overgaard J: Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 2007, 84: 102-103. 10.1016\/j.radonc.2007.05.011","journal-title":"Radiother Oncol"},{"key":"355_CR3","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1056\/NEJM199710023371401","volume":"337","author":"M Overgaard","year":"1997","unstructured":"Overgaard M, Hansen PS, Overgaard J, et al.: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997, 337: 949-955. 10.1056\/NEJM199710023371401","journal-title":"N Engl J Med"},{"key":"355_CR4","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0360-3016(90)90214-5","volume":"19","author":"M Overgaard","year":"1990","unstructured":"Overgaard M, Christensen JJ, Johansen H, et al.: Evaluation of radiotherapy in high-risk breast cancer patients: report from the Danish Breast Cancer Cooperative Group (DBCG 82) Trial. Int J Radiat Oncol Biol Phys 1990, 19: 1121-1124. 10.1016\/0360-3016(90)90214-5","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"355_CR5","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/jnci\/93.13.979","volume":"93","author":"P Eifel","year":"2001","unstructured":"Eifel P, Axelson JA, Costa J, et al.: National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001, 93: 979-989. 10.1093\/jnci\/93.13.979","journal-title":"J Natl Cancer Inst"},{"key":"355_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clon.2007.10.004","volume":"20","author":"IH Kunkler","year":"2008","unstructured":"Kunkler IH, Canney P, van TG, et al.: Elucidating the role of chest wall irradiation in intermediate risk breast cancer: The MRC\/EORTC SUPREMO trial. Clin Oncol (R Coll Radiol) 2008, 20: 31-34.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"355_CR7","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/jnci\/djh297","volume":"97","author":"J Ragaz","year":"2005","unstructured":"Ragaz J, Olivotto IA, Spinelli JJ, et al.: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 2005, 97: 116-126. 10.1093\/jnci\/djh297","journal-title":"J Natl Cancer Inst"},{"key":"355_CR8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/S0360-3016(99)00096-6","volume":"44","author":"JR Harris","year":"1999","unstructured":"Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ: Consensus Statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 1999, 44: 989-990. 10.1016\/S0360-3016(99)00096-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"355_CR9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2001.19.5.1539","volume":"19","author":"A Recht","year":"2001","unstructured":"Recht A, Edge SB, Solin LJ, et al.: American Society of Clinical Oncology. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001, 19: 1539-1569.","journal-title":"J Clin Oncol"},{"key":"355_CR10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1200\/JCO.1998.16.8.2886","volume":"16","author":"A Recht","year":"1998","unstructured":"Recht A, Bartelink H, Fourquet A, et al.: Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol 1998, 16: 886-2889.","journal-title":"J Clin Oncol"},{"key":"355_CR11","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1002\/cncr.20969","volume":"103","author":"PT Truong","year":"2005","unstructured":"Truong PT, Berthlet E, Lee J et al: The prognostic significance of the percentage of positive\/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer 2005, 103: 2006-2014. 10.1002\/cncr.20969","journal-title":"Cancer"},{"key":"355_CR12","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.radonc.2003.10.015","volume":"70","author":"M Voordeckers","year":"2004","unstructured":"Voordeckers M, Vinh-Hung V, Van de Steene J, Lamote J, Storme G: The lymph node ratio as prognostic factor in node-positive breast cancer. Radiother Oncol 2004, 70: 225-230. 10.1016\/j.radonc.2003.10.015","journal-title":"Radiother Oncol"},{"key":"355_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1053\/ejso.2002.1239","volume":"28","author":"BCH Van der Wal","year":"2002","unstructured":"Van der Wal BCH, Butzelaar RMJM, van der Meij S, Boermeester MA: Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in Stage I and II breast cancer. Eur J Surg Oncol 2002, 28: 481-489. 10.1053\/ejso.2002.1239","journal-title":"Eur J Surg Oncol"},{"key":"355_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/01.COC.0000071941.70772.DC","volume":"27","author":"LJ Megale Costa","year":"2004","unstructured":"Megale Costa LJ, Soares HP, Gaspar HA, et al.: Ratio between positive lymph nodes and total dissected axillary lymph nodes as an independent prognostic factor for disease-free survival in patients with breast cancer. Am J Clin Oncol 2004, 27: 304-306. 10.1097\/01.COC.0000071941.70772.DC","journal-title":"Am J Clin Oncol"},{"key":"355_CR15","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.ijrobp.2004.08.009","volume":"61","author":"PT Truong","year":"2005","unstructured":"Truong PT, Olivotto IA, Kader HA, et al.: Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 2005, 61: 1337-1347. 10.1016\/j.ijrobp.2004.08.009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"355_CR16","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1200\/JCO.2008.18.7062","volume":"27","author":"NS Russell","year":"2009","unstructured":"Russell NS, Kunkler IH, Tienhoven G, Canney PA, Thomas J, Bartlett J, et al.: Postmastectomy Radiotherapy: Will the Selective Use of Postmastectomy Radiotherapy Study End the Debate? J Clin Oncol 2009,27(6):996-997. 10.1200\/JCO.2008.18.7062","journal-title":"J Clin Oncol"},{"issue":"1","key":"355_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.radonc.2007.05.011","volume":"84","author":"R Arriagada","year":"2007","unstructured":"Arriagada R, L\u00ea MG: Number of positive axillary lymph nodes and post-mastectomy radiotherapy effectin breast cancer patients. Radiother Oncol 2007,84(1):102-103. 10.1016\/j.radonc.2007.05.011","journal-title":"Radiother Oncol"},{"key":"355_CR18","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1200\/JCO.2005.02.5676","volume":"24","author":"SH Cheng","year":"2006","unstructured":"Cheng SH, Horng CF, West M, et al.: Genomic prediction of locoregional recurrence after mastectomy in breast cancer. J Clin Oncol 2006, 24: 4594-602. 10.1200\/JCO.2005.02.5676","journal-title":"J Clin Oncol"},{"issue":"1","key":"355_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jnci\/djj002","volume":"98","author":"Gebski Val","year":"2006","unstructured":"Val Gebski, Marivic Lagleva, Anthony Keech, John Simes, Langlands AllanO: Survival Effects of Postmastectomy Adjuvant Radiation Therapy Using Biologically Equivalent Doses: A Clinical Perspective. J Natl Cancer Inst 2006,98(1):26-38. 10.1093\/jnci\/djj002","journal-title":"J Natl Cancer Inst"},{"key":"355_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/jnci\/dji067","volume":"97","author":"SH Giardona","year":"2005","unstructured":"Giardona SH, Kuo YF, Freeman JL, et al.: Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005, 97: 419-424. 10.1093\/jnci\/dji067","journal-title":"J Natl Cancer Inst"},{"key":"355_CR21","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1080\/02841860310014444","volume":"42","author":"LE Rutqvist","year":"2003","unstructured":"Rutqvist LE, Rose C, Cavallin-Stahl E: A systematic overview of radiation therapy effects in breast cancer. Acta Oncol 2003, 42: 532-545. 10.1080\/02841860310014444","journal-title":"Acta Oncol"},{"key":"355_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0167-8140(00)00204-8","volume":"55","author":"J Van de Steene","year":"2000","unstructured":"Van de Steene J, Soete G, Storme G: Adjuvant radiotherapy for breast cancer significantly improves overall survival: The missing link. Radiother Oncol 2000, 55: 263-272. 10.1016\/S0167-8140(00)00204-8","journal-title":"Radiother Oncol"},{"key":"355_CR23","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1200\/JCO.2000.18.6.1220","volume":"18","author":"TJ Whelan","year":"2000","unstructured":"Whelan TJ, Julian J, Wright J, et al.: Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000, 18: 1220-1229.","journal-title":"J Clin Oncol"},{"key":"355_CR24","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jnci\/djj052","volume":"98","author":"C Sotiriou","year":"2006","unstructured":"Sotiriou C, Wirapati P, Loi S, et al.: Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006, 98: 262-272. 10.1093\/jnci\/djj052","journal-title":"J Natl Cancer Inst"},{"key":"355_CR25","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1158\/1078-0432.CCR-06-0805","volume":"12","author":"B Kreike","year":"2006","unstructured":"Kreike B, Halfwerk H, Kristel P, et al.: Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy. Clin Cancer Res 2006, 12: 5705-5712. 10.1158\/1078-0432.CCR-06-0805","journal-title":"Clin Cancer Res"},{"key":"355_CR26","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1002\/1097-0142(19811015)48:8<1863::AID-CNCR2820480825>3.0.CO;2-U","volume":"48","author":"B Fisher","year":"1981","unstructured":"Fisher B, Wolmark N, Redmond C, et al.: Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers. Cancer 1981, 48: 1863-1872. 10.1002\/1097-0142(19811015)48:8<1863::AID-CNCR2820480825>3.0.CO;2-U","journal-title":"Cancer"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-6-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-6-28\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-6-28.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T23:52:47Z","timestamp":1548201167000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-6-28"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,30]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-6-28","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,30]]},"article-number":"28"}}